LETTER
O-Allylic Substitution of Hydroxylamine Derivatives
569
2.03 (2 H, m), 1.56 (2 H, m), 1.43 (9 H, s); 13C NMR (125 MHz ,
CDCl3) δ 154.8, 136.4, 135.6, 117.0, 115.9, 80.9, 79.1, 56.9, 28.3,
23.9, 23.6; HRMS: Calcd for C13H21NO3 (M+): 239.1521, Found:
239.1525.
(3) (a) Evans, P. A.; Leahy, D. K. J. Am. Chem. Soc. 2002, 124,
7882. (b) Kim, H.; Lee, C. Org. Lett. 2002, 4, 4369.
(4) Procedures for preparing the allylated hydroxylamines often
require lengthy linear manipulation. See: (a) Bull, S. D.;
Davies, S. G.; Domingez, S. H.; Jones, S.; Price, A. J.;
Sellers, T. G. R.; Smith, A. D. J. Chem. Soc., Perkin Trans.
1 2002, 2141. (b) Ishikawa, T.; Kawakami, M.; Fukui, M.;
Yamashita, A.; Urano, J.; Saito, S. J. Am. Chem. Soc. 2001,
123, 7734.
(5) (a) Murahashi, S.; Imada, Y.; Taniguchi, Y.; Kodera, Y.
Tetrahedron Lett. 1988, 29, 2973. (b) Genet, J.-P.;
Thorimbert, S.; Touzin, A.-M. Tetrahedron Lett. 1993, 34,
1159.
(6) The iridium-catalyzed regioselective allylic amination was
recently achieved by Takeuchi’s group. See: (a) Takeuchi,
R.; Ue, N.; Tanabe, K.; Yamashita, K.; Shiga, N. J. Am.
Chem. Soc. 2001, 123, 9525. (b) Takeuchi, R.; Shiga, N.
Org. Lett. 1999, 1, 265. (c) For a review, see: Takeuchi, R.
Synlett 2002, 1954.
Major isomer of 14d: IR (CHCl3) 1697 cm–1; 1H NMR (500 MHz ,
CDCl3) δ 7.37–7.30 (10 H, m), 5.95–6.08 (4 H, m), 5.12–5.33 (12
H, m), 4.63–4.64 (2 H, m), 4.55 (2 H, br s), 1.61–2.15 (8 H, s); 13
C
NMR (125 MHz , CDCl3) δ 155.3, 136.1, 135.9, 135.0, 128.3, 127.9
(2 C), 117.4, 116.4, 79.4, 67.2, 56.6, 23.6, 23.2; HRMS: Calcd for
C16H19NO3 (M+): 273.1365, Found: 273.1358.
Acknowledgement
This work was supported in part by The Japan Health Sciences
Foundation and Grant-in-Aid for Scientific Research (C) from the
Ministry of Education, Culture, Sports, Science and Technology of
Japan.
(7) Recently, the effect of a hydroxylamine tether on
intramolecular Diels-Alder reactions was reported. See:
Ishikawa, T.; Senzaki, M.; Kadoya, R.; Morimoto, T.;
Miyake, N.; Izawa, M.; Saito, S. J. Am. Chem. Soc. 2001,
123, 14607.
(8) For recent reviews on ring-closing methathesis, see:
(a) Grubbs, R. H. Tetrahedron 1998, 54, 4413. (b) Pandit,
U. K.; Overleeft, H. S.; Borer, B. C.; Bieraugel, H. Eur. J.
Org. Chem. 1999, 9.
References
(1) For recent reviews, see: (a) Johannsen, M.; Jorgensen, K. A.
Chem. Rev. 1998, 98, 1689. (b) Trost, B. M. Chem. Pharm.
Bull. 2002, 50, 1.
(2) (a) Keinan, E.; Sahai, M.; Roth, Z. J. Org. Chem. 1985, 50,
3558. (b) Trost, B. M.; Tenaglia, A. Tetrahedron Lett. 1988,
29, 2931. (c) Goux, C.; Massacret, M.; Lhoste, P.; Sinou, D.
Organometallics 1995, 14, 4585. (d) Satoh, T.; Ikeda, M.;
Miura, M.; Nomura, M. J. Org. Chem. 1997, 62, 4877.
(e) Trost, B. M.; McEachern, E. J.; Toste, F. D. J. Am. Chem.
Soc. 1998, 120, 12702. (f) Konno, T.; Nagata, K.; Ishihara,
T.; Yamanaka, H. J. Org. Chem. 2002, 67, 1768.
(9) The cyclic products 14c–e were obtained as a diastereomeric
mixture in about 10:1 ratio by 1H NMR, although these
stereochemistries have not be determined.
Synlett 2003, No. 4, 567–569 ISSN 0936-5214 © Thieme Stuttgart · New York